Close Menu

Publishing company Springer has acquired BioMed Central, the largest open access publisher with more than 180 peer-reviewed journals. Springer's Derk Haank said in a statement, "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.